Oncolytics Biotech Inc T.ONC

? for the board

[pelaboost]

The question is regarding Noteable's last post. The excerpt you used from the release sounds like the TIL score is hypothetically to be used as a screening test. That is to say, it seems like a patient could be treated before the actual trial to determine if the patient should actually enter the trial.

Am I even close on this? It would be a novel way to guide patients to their best options. Not to mention saving money and hardship.

TIA

[JohnnyYeg]

I don't think it's hypothetical as much as confirmed. And the payient is "tested" for it before the trial; the trial is the treatment.

[inthno]

The test cannot be done ahead of time to see if the patient will respond. What is done is usually baseline bloodwork and or biopsies so they will have their base to start with and then tests will be done again usually within 2-3 weeks depending upon the protocols at this time they will be able to see if the treatment is working as a result of the til infiltration. From the pr. “Translational

[m00nsh0ts]

Affirm,= state as a fact, assert strongly and publicly.

[m00nsh0ts]

Affirm,= state as a fact, assert strongly and publicly.

[Quentin30]

and deliberate choice of wording... different to confirm... i.e. prove, ONCY is still mincing words to suggest more than is actually the case... If they had confirmed a biomarker, they would have used exactly that language...

[inthno]

What is nice about having a confirmed biomarker is that after the observation period of what ever they decide in the trial protocols have been done and patient assessed they then decide if that patient will continue on with treatment as they would be most likely to respond and the patients that did not pass the benchmark would then be removed from the trial and not be considered evaluable so as